Wai-Yee Chan, Ph.D.
Professor, Department of Pediatrics,
Georgetown University Children's Medical Center,
3800 Reservoir Road, NW,
Washington,
DC 20007.
Tel: (202) 687-7068
E-mail:
chanw@georgetown.edu
Adjunct Investigator,
Laboratory of Clinical Genomics
National Institute of Child Health and Human
Development,
National Institutes of Health
Tel: (301) 451-8821
Fax: (301) 480-4700
Email: chanwy@mail.nih.gov
NATIONALITY:
Naturalized US Citizen, 1984.
EDUCATION:
1970-74 B. Sc.,
Hon., 1st Class (Major: Chemistry; Minor: Biochemistry), the Chinese
University of Hong Kong, Hong Kong.
1974-77 Ph.D. (Biochemistry),
University of Florida, Gainesville, FL. Advisor: Dr. Owen M. Rennert.
1977-79 Fellow, Division of Genetics,
Endocrinology & Metabolism, Department of Pediatrics, University
of Oklahoma, Oklahoma City, OK. Director: Owen M. Rennert, MD.
1982
Visiting Scientist, Department of Biochemistry, University of Washington,
Seattle, WA. Supervisor: Earl W. Davie, Ph.D.
APPOINTMENTS:
1979-82
Director, Clinical Trace Metals
Diagnostic Lab, Department of Pediatrics, University of
Oklahoma, Oklahoma City, OK.
1979-89 Assistant
to Associate Professor, Department of Pediatrics (Tenured 1983) and Department
of Biochemistry & Molecular Biology (Adjunct), University of Oklahoma,
Oklahoma City, OK.
1980-87
Scientific Director, Biochemical Genetics Lab, Oklahoma Children's
Hospital, Okla City, OK.
1981-87
Consultant, Medical Service, Veteran's Administration Medical Center,
Oklahoma City, OK.
1982-88
Scientific Director, Trace Metals Diagnostic Lab, State of Oklahoma
Teaching Hospitals, Oklahoma City, OK.
1987-89
Associate Member, Oklahoma Medical Research Foundation, Oklahoma City,
OK.
1989-Present Affiliate
Member, Oklahoma Medical Research Foundation, Oklahoma City, OK.
1989-Present Professor, Department of Pediatrics
(Tenured 1990), Departments of Biochemistry & Molecular Biology and Cell
Biology (Secondary), Georgetown University, Washington, DC.
1990-Present Member,
Vincent T. Lombardi Cancer Center, Georgetown University, Washington, DC.
1993-2000 Director,
Molecular Genetic Diagnostic Lab, Georgetown University Children's Medical
Center, Washington, DC.
1998-2000 Chief,
Division of Genetics and Metabolic Diseases, Department of Pediatrics,
Georgetown University, Washington, DC.
2001-Present Adjunct Investigator, Laboratory
of Clinical Genomics, NICHD, NIH, Bethesda, MD.
BOARD CERTIFICATION:
1. Certified Nutrition Specialist, Certificate # 00049,
The Certification Board for Nutrition Specialists, August 1993.
2. Director, Molecular Genetic Diagnostic Laboratory,
CLIA ID#: 09D0903844, Health Care Financing
Administration, DHHS, 1995-2000.
PATENT:
1. Pregnancy Specific Proteins Applications
Sole Inventor
US Patent No. 5,169,835; Issue date: December 8, 1992.
Australian Patent No. 645965; Issue date: December 6, 1993.
Canadian Patent No. 805-105; European Patent No.
90902488.7; Japanese Patent No. 4-504655.
2. Retinoic Acid Inducible DNA Sequences and
Polypeptides Expressed Thereby and Their Use in Promoting
Alveolar Development
U.S.S.N. 09/330,004, European Patent No. 99930221.9-2107; Japanese
Patent No. 2000-553125
Inventor: 60%.
Co-Inventors: Donald Massaro 20%, Gloria Massaro 20%
3. In Vivo Assay for Identifying Nucleic Acid Sequences
Involved in Alveolar Loss, Development and Nucleic
Acid Sequences Identified Thereby
Inventors: Donald Massaro 40%, Gloria Massaro 40%,
Wai-Yee Chan 20%.
4. Method Evolved for Recognition of Thrombophilia
(MERT)
Inventors: Cigdem Dogulu, Owen M. Rennert, Wai-Yee Chan
US patent
application filed: January 15, 2004. DHHS
reference no. E-282-2003/0-us-01
SOCIETY
MEMBERSHIPS:
American Society of Human Genetics, 1977
Society for Pediatric Research, 1980
American College of Nutrition, 1981
American Society for Biochemistry and Molecular Biology,
1982
Society of Chinese Bioscientists in America, (Oklahoma
Representative, 1985-89), 1985
American Institute of Immunology, 1987
Endocrine Society, 1990
Association of Chinese Geneticists in America,
(President-elect 2002-03, President 2003-04) 1999
CONSULTANTSHIP:
1.
Mitsubishi Kasei Corporation, Yokohama, Japan. 1993-1994.
2. Bayer
Corporation, Pharmaceutical Division, Berkeley, California. 1998-2000.
3.
AstraZeneca Pharmaceuticals LP, Wilmington, Delaware. 2000-2004.
HONORS AND AWARDS:
Awards:
1.
Scholarship for Chemistry, the Chinese University of Hong Kong, 1972‑74.
2. Tak Shing Scholarship for Biochemistry,
the Chinese University of Hong Kong, 1973‑74.
3.
Honors, First Class, Chemistry, the Chinese University of Hong Kong,
1974.
4.
Listed in : American Men and
Women of Science, 1982; Who's Who in the World, 1984, 1998;
International Who's Who in Medicine,
1986; Who's Who in Science and Engineering, 1991;
Who's Who in Medicine and
Healthcare, 1997.
5. Merrick Award for Outstanding
Biomedical Research, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma,
1988.
6. Service Award, Department of
Biochemistry and Molecular Biology, University of Oklahoma Health Sciences
Center, Oklahoma City, July, 1989.
7.
Honorary Member, Chinese
American Medical Association, New York, 1992.
8.
Distinguished Faculty Tutor,
School of Medicine, Georgetown University, 1997.
Visiting Professorship:
1.
Visiting Professor, Cancer
Institute, Chinese Academy of Medical Sciences, and Institute of Basic Clinical
Sciences, China-Japan Friendship
Hospital, Beijing, China, May 12-15, 1987.
2. Visiting Professor, Department of
Biochemistry and Molecular Biology, University of Oklahoma Health Sciences
Center, Oklahoma City, Oklahoma, March 18-20, 1991.
3.
Visiting Scholar, Shaw College, Chinese University of Hong Kong, Hong
Kong, June 29-July 5, 1993.
Invited Participation in Delegations:
1. American
Delegate to the First U.S.‑China Bilateral Conference on Protein in Biology and
Medicine. Shanghai and Beijing, China, May 24‑June 12, 1981.
2. American
Delegate, the Second U.S.‑China Bilateral Conference on Protein in Biology and
Medicine. Oklahoma City, OK, June 11‑13, 1983.
3. American
Delegate, U.S.A.-P.R.C. Tumor Biology Conference. Oklahoma Medical Research
Foundation, Oklahoma City, OK, April 21-22, 1986.
4.
Delegation from the Oklahoma Medical Research Foundation to SunYet-sen
University of Medical Sciences, Guangzhou, Institute of Biochemistry, Academia
Sinica, Shanghai, and Chinese Academy of Medical Sciences, and China-Japan
Friendship Hospital, Beijing, China, June to August, 1986.
5. US Delegate, Briefing on Medical Application of
Modern Biotechnology to Norwegian Parliamentary Committee on Health and Social
Affairs. Royal Norwegian Embassy, Washington, DC. September 7, 1990.
6. Centennial Reunion Conference of the US-China
Bilateral Meeting on Proteins in Biology and Medicine,
Maui, Hawaii, June 20-24, 1992.
Conference
Organizer, Session Chair, and Invited Presentation in Symposia:
1. Scientific Working Conference on Cystic Fibrosis. Cystic Fibrosis Foundation and National
Institutes of Health, Padre Island, TX, March 4-7, 1979.
2. Ross Clinical Research Conference on Meeting Nutritional
Goals for Low-Birth-Weight Infants. Ross Laboratories, Tarpon Springs, FL,
October 2‑4, 1980.
3. Manganese in Metabolism and Enzyme Function Conference.
Pennsylvania State University, University Park, PA, October 7-10, 1984.
4. Symposium on Manganese Nutrition. American Chemical Society,
Anaheim, CA. September 7-12, 1986.
5. The First International CEA Workshop. McGill Cancer Center, McGill
University, Montreal, Canada, June 11-14, 1990.
6. The Second International PSG/CEA Workshop
(Co-Organizer). NIH/Georgetown University, Washington, DC, June 17-20, 1991.
7. The Third International PSG/CEA Workshop. University
of Umea, Umea, Sweden, June 14-17, 1992.
8. The Fourth International PSG/CEA Workshop, Deaconess
Hospital, Harvard Medical School, Boston, August 22-25, 1993.
9. The Fifth International PSG/CEA Workshop, Freiburg
University, Freiburg, Germany, July 18-21, 1994.
10. The Sixth International PSG/CEA
Workshop, McGill Cancer Center, McGill University, Montreal, Canada, September
6-8, 1995.
11. Symposium on the Chemistry and
Molecular Biology of Blood Coagulation, Battelle Conference Center, Seattle, WA, October 24,
1997.
12. Molecular abnormalities of LH
action. Symposium on Disorders of Gonadotropin Secretion and Action, 80th
Annual Meeting of the Endocrine Society, June 24, 1998.
13. The Impact of Culture on Health
Seeking Behavior Panel. (Panelist) Washington DC Area Geriatric Education
Center Consortium Spring 1999 Enrichment Series: Multicultural Issues in
Aging. Howard University,
Washington, DC, May 27, 1999.
14. Spirituality of Aging for Minority Population
(Panelist). Washington DC Area Geriatric
Education Center
Consortium Spring 2000 Enrichment
Series: Multicultural Issues in Aging.
Howard University,
Washington, DC. June 2, 2000.
15. TWGH-CUHK Eddie Wang Symposium on
Complementary Chinese and Western Medicine Symposium – Integrated Approach,
Hong Kong, Feb 27-28, 2004.
17. Session
on Y Chromosome Evolution, Population and Molecular Genetics (Co-Chair), 10th
SCBA International Conference, Beijing, China, July 18-23, 2004.
18. Wuhan Frontier of Biomedical Science Satellite
Workshop of SCBA, Wuhan, China, July 25-26, 2004.
SERVICE ACTIVITIES:
Professional Service
I. Grant
Review and Study Sections:
A. International:
1. Research Grants Council,
University Grants Committee (Formerly University and Polytechnic Grants
Committee), Hong Kong, Overseas Reviewer,
1991-93, 1995-98.
2. Lottery Health Research, New Zealand Lottery Grants Board, Department
of Internal Affairs, New
Zealand, Reviewer,
1993.
3. Health Research Council of New Zealand, Reviewer, 1996-present.
4. USDA Research &
Scientific Exchanges/Portuguese Ministry of Science and Technology/European
Community, USDA, Reviewer, 1997.
5. The Wellcome Trust and Health Research
Board, United Kingdom, Reviewer, 1999.
B. National:
1. Site Visit Committee, National Institute of Arthritis, Diabetes,
Digestive and Kidney Diseases, NIH, for
Hepatobiliary Center in Denver, Colorado, August, 1984.
2. Special Study Section, Physiology of
Lactation and Biology of Human Milk, National Institute of Child
Health and Human
Development, NIH, July, 1985.
3. Biochemistry Subcommittee, Drug Abuse
Biomedical Research Review Committee, National Institute of
Drug Abuse, NIH, Ad Hoc
Reviewer, October, 1993, 1994.
4. Reproductive Biology Study Section, National
Institutes of Health, Ad Hoc Reviewer, October, 1994.
5.
Special Emphasis Panel, National Institutes of Child Health and Human
Development, NIH, April 23,
1998.
6. Endocrinology,
Metabolism, Nutritional and Reproductive Sciences Study Section, ZRG1 F06-20,
NIH,
October,
2001 - present.
7. Ad Hoc Reviewer,
Neonatal Research Network, National Institute of Child Health and Human
Development, NIH, April,
2004.
II. Journal
Editorial Activities:
A. Editorial
Boards:
1. Journal of the American College
of Nutrition, 1982 ‑ Present.
2. Journal of Endocrine Genetics,
1999 - present.
3.
Journal of Current Molecular Medicine, 1999 - present.
4. Annals of Traditional Chinese
Medicine, 2004 – present.
B. Reviewer:
Science, Proceedings of the National Academy of Sciences,
USA, Biochemistry, New England Journal of
Medicine, American Journal of Medical
Genetics, Journal of Immunology, Journal of Clinical
Endocrinology and Metabolism, Gene, Human
Genetics, European Journal of
Biochemistry, Biochimica et
Biophysica Acta, Pediatrics, Life
Sciences, American Journal of
Clinical Nutrition, DNA and Cell Biology,
Journal of Nutritional Biochemistry,
Proceedings for the Society of Experimental Biology and Medicine,
DNA Sequences, Molecular Reproduction and
Development, Asian Journal of Andrology.
III. Other Review Activities:
1. Literature Selection Technical Review Committee,
National Library of Medicine, Guest Reviewer, 1996.
2. Selection Committee, Japanese Society for the
Promotion of Science (JSPS) Fellowship Program, Fogarty
International Center, National Institutes of Health, December 2, 1996.
3. Selection Committee, Asia Pacific Economic Council (APEC) Youth
Science Festival, International
Directorate, American
Association for the Advancement of Sciences, 2000, 2003.
4.
Review Panel, the Korea-U.S. Science and Engineering Summer Camp in Seoul,
South Korea, American
Association
for the Advancement of Science, April, 2002.
IV. Activities at Foreign Academic Institutes:
1. Dissertation/Thesis External
Reviewer, Master of Philosophy and Doctor of Philosophy, Division of
Biochemistry, the Chinese University of Hong Kong, 1984, 1989-1994,
1998, 2001-present.
2. External/Visiting Examiner,
Undergraduate Program of Biochemistry, Undergraduate Examination Board,
the Chinese University of Hong Kong, Hong Kong,
1994-97.
3. External Assessor, Personnel
Department, the Chinese University of Hong Kong, Hong Kong S.A.R., China,
1995, 1997, 1999-2002, 2004.
4. External Examiner, First
Professional Degree, the Chinese University of Hong Kong School of
Medicine, Hong Kong S.A.R.,
China, 2001-present.
5. Special Advisor to the
Chancellor (2001-present) and Member, College Council (2002-present), the
Macau
Millennium College, Macau S.A.R., China.
6. Member, Scientific Advisory Board, Area of
Excellence in Chinese Medicine Research and Further Development, Hong Kong
S.A.R., China, 2002-2007.
7. Liaison, Montgomery College-Millennium College Faculty/Student
Exchange Program, 2003-present.
NIH/University
Service:
I. National Institutes of Health:
1. Coordinator, Graduate Supervisory Committee,
NICHD-CUHK Graduate Partnership Program, NICHD, 2003-present.
II. Georgetown University:
1.
Genetics Graduate Program Committee, 1989-95.
2.
Genetics Clinical Fellowship Committee, 1989-95.
3.
Neuroscience Task Force, 1990-93.
4.
Subcommittee on Reproductive Failure/Genetics, Perinatal Task Force, 1990-93.
5.
Georgetown University Hospital Molecular Diagnostic Laboratory Committee,
1993-97.
6.
Institutional Biosafety Committee, 1996–2002.
7. Medical
Center Research Committee, 1998-2001.
8.
Sub-committee on Pre-Clinical Education of the Committee on Medical Education,
1998-present.
9.
Executive Committee, Department of Biochemistry & Molecular Biology,
2003-present.
10. Committee on Appointment and Promotion, Georgetown
University Medical Center, 2003-present.
11. Development and Child Health Research Initiative
Task Force, Georgetown University, 2004.
III. Oklahoma Medical Research
Foundation:
1.
Recombinant DNA subcommittee, 1987-88.
2. Library
Advisory committee, 1988-89.
III.
University of Oklahoma:
1.Graduate
Curriculum Committee (1981-83), Graduate Admissions and Student Recruitment
Committee
(1986-89), and Faculty Advisory Committee
(1988-89), Department of Biochemistry & Molecular
Biology.
2. Research and Education Computer
Advisory Committee, 1983‑86.
3. Affirmative Action Committee, 1984‑87.
4. Planning Committee, Mid‑American
Molecular Biology Colloquium, 1986‑87.
5. Medical Alumni Association Research
Award Committee, 1989.
Public Service:
I. National and International Scientific Organizations:
1. American
Biographical Institute, Inc., Honorary Educational Advisory Board, 1984‑89.
2. Society
of Sigma Xi, University of Oklahoma Chapter, Award Committee, 1984‑85;
Treasurer, 1985‑88.
3. Society
of Chinese Bioscientist in America, Oklahoma Representative, 1985‑89.
4. American
Association for the Advancement of Science, Advisory Committee, Pacific Rim
Initiative,
1997-2003.
5.
Association of Chinese Geneticists in America, Board of Directors,
2000-2002, President-Elect, 2002-2003, President 2003-2004,.
SCHOLARSHIP AND RESEARCH:
A. RESEARCH SUPPORT:
Past Support from NIH (Foundation and Industrial Support Not Listed):
1. Identification and Quantitation of Cystic Fibrosis
Factors. (Co-Investigator) RFP‑NHLBI‑HR‑77‑3, NIH. 1977 – 1981.
2. Human Milk Peptide, Metallo‑Peptides
and Trace Metals (Co-PI). RO1 HD 12465, NIH. 1978 – 1981.
3. Nutritional Role of Manganese
Binding Molecules in Milk (PI). RO1 HD 16730, NIH. 1983 – 1986.
4. Genetic Studies of Pregnancy
Specific b1 Glycoprotein (PI). RO1 HD 21793, NIH. 1986 – 1993.
5.
Project 1: Role of PSG Proteins in the Testis (PI).
Program Project: Cell Biology of Testis. PO1HD24633, NIH, 1992 - 1996
6.
Molecular Genetics of Pregnancy
Specific Glycoproteins (PI). IPA, NCHGRI, NIH. 1995.
7. The Promonocyte Receptor for
PSG11s. (PI) RO1 HD31553, NIH. 1995 - 1998
8. Experimental Emphysema: Studies
on Remediation. (Co-Investigator)
RO1 HL59432, NIH. 1997 - 1999.
9. Research Training in
Developmental Immunology.T32 HD07185-11. NIH. 1994 – 1999.
10.
Remediation of Emphysema: Mechanism, Characterization. (Co-Investigator) 1RO1
HL60115-01A, NIH, 1998 – 2002.
Current Support:
1. Establishment of a
developmental genomics program in NICHD. IPA, NICHD, NIH. 100%,
01/01/2001 – 09/30/2005.
$ 942,143.00, current year $ 228,652.50.
2. Section on Developmental Genomics, NICHD intramural support for the
laboratory, 100%,